TY - JOUR
T1 - Type 1 and type 2 diabetes predisposed to higher Nd:YAG capsulotomy rates following cataract surgery
T2 - analysis of 53,471 consecutive cases
AU - Cunha, Mariana
AU - Elhaddad, Omar
AU - Yahalomi, Tal
AU - Avadhanam, Venkata
AU - Tole, Derek
AU - Darcy, Kieran
AU - Levinger, Eliya
AU - Tuuminen, Raimo
AU - Achiron, Asaf
N1 - Publisher Copyright:
© 2024 Canadian Ophthalmological Society
PY - 2024/12
Y1 - 2024/12
N2 - Objective: To assess the effect of diabetes type on Nd:YAG capsulotomy rates following cataract surgery. Design: A retrospective cohort study. Methods: All patients who underwent cataract extraction at the Department of Ophthalmology, Bristol Eye Hospital, Bristol, UK, between 2003 and 2017 were included. The Nd:YAG capsulotomy rate following cataract surgery was assessed and compared between nondiabetic, type 1 diabetes (T1D), and type 2 diabetes (T2D) patients. Multivariate Cox regression analysis controlling for age and sex was used to estimate hazard ratios for Nd:YAG laser capsulotomies. Results: Included were 53,471 consecutive cataract surgeries. Overall, 42,651 eyes (79.8%) were in nondiabetic patients, 823 eyes (1.5%) were in T1D patients, and 9,997 eyes (18.7%) were in T2D patients. The mean follow-up time was 6.8 ± 4.2 years. In univariate analysis, the eyes of T1D patients (p < 0.001) and T2D patients (p = 0.003) had significantly higher Nd:YAG laser capsulotomy rates than the eyes of nondiabetic patients. In Cox regression analysis adjusted for the patient's age and sex, DM1 (HR 1.692, 95%CI 1.390-2.059, P<0.001) and DM2 (HR 1.157, 95%CI 1.075-1.244, P<0.001) remained significantly predictive for higher Nd:YAG laser capsulotomy rates. Conclusion: In our large cohort study, patients with T1D and T2D were predisposed to high risk for Nd:YAG capsulotomy following cataract surgery. This study may be beneficial and raise awareness regarding the assessment of posterior capsular opacification development in pseudophakic diabetic patients, particularly those with T1D. The significance of ophthalmology screening for diabetes individuals is further supported by this issue.
AB - Objective: To assess the effect of diabetes type on Nd:YAG capsulotomy rates following cataract surgery. Design: A retrospective cohort study. Methods: All patients who underwent cataract extraction at the Department of Ophthalmology, Bristol Eye Hospital, Bristol, UK, between 2003 and 2017 were included. The Nd:YAG capsulotomy rate following cataract surgery was assessed and compared between nondiabetic, type 1 diabetes (T1D), and type 2 diabetes (T2D) patients. Multivariate Cox regression analysis controlling for age and sex was used to estimate hazard ratios for Nd:YAG laser capsulotomies. Results: Included were 53,471 consecutive cataract surgeries. Overall, 42,651 eyes (79.8%) were in nondiabetic patients, 823 eyes (1.5%) were in T1D patients, and 9,997 eyes (18.7%) were in T2D patients. The mean follow-up time was 6.8 ± 4.2 years. In univariate analysis, the eyes of T1D patients (p < 0.001) and T2D patients (p = 0.003) had significantly higher Nd:YAG laser capsulotomy rates than the eyes of nondiabetic patients. In Cox regression analysis adjusted for the patient's age and sex, DM1 (HR 1.692, 95%CI 1.390-2.059, P<0.001) and DM2 (HR 1.157, 95%CI 1.075-1.244, P<0.001) remained significantly predictive for higher Nd:YAG laser capsulotomy rates. Conclusion: In our large cohort study, patients with T1D and T2D were predisposed to high risk for Nd:YAG capsulotomy following cataract surgery. This study may be beneficial and raise awareness regarding the assessment of posterior capsular opacification development in pseudophakic diabetic patients, particularly those with T1D. The significance of ophthalmology screening for diabetes individuals is further supported by this issue.
UR - http://www.scopus.com/inward/record.url?scp=85189427008&partnerID=8YFLogxK
U2 - 10.1016/j.jcjo.2024.02.014
DO - 10.1016/j.jcjo.2024.02.014
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 38513717
AN - SCOPUS:85189427008
SN - 0008-4182
VL - 59
SP - 380
EP - 385
JO - Canadian Journal of Ophthalmology
JF - Canadian Journal of Ophthalmology
IS - 6
ER -